Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
- PMID: 30950210
- PMCID: PMC6558487
- DOI: 10.1002/cam4.2148
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Abstract
Successful treatment of cancer remains a challenge, due to the unique pathophysiology of solid tumors, and the predictable emergence of resistance. Traditional methods for cancer therapy including radiotherapy, chemotherapy, and immunotherapy all have their own limitations. A novel approach is bacteriotherapy, either used alone, or in combination with conventional methods, has shown a positive effect on regression of tumors and inhibition of metastasis. Bacteria-assisted tumor-targeted therapy used as therapeutic/gene/drug delivery vehicles has great promise in the treatment of tumors. The use of bacteria only, or in combination with conventional methods was found to be effective in some experimental models of cancer (tumor regression and increased survival rate). In this article, we reviewed the major advantages, challenges, and prospective directions for combinations of bacteria with conventional methods for tumor therapy.
Keywords: bacteriotherapy; cancer; chemotherapy; immunotherapy; radiotherapy; tumoricidal agents.
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures
References
-
- Torre L, Bray F, Siegel R, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87‐108. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394‐424. - PubMed
-
- Datta Nr, Ordóñez SG, Gaipl Us, et al. Local hyperthermia combined with radiotherapy and‐/or chemotherapy: Recent advances and promises for the future. Cancer Treat Rev. 2015;41:742‐753. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources